PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Risk of HIV treatment failure present even in those with low viral load

Study proposes new benchmarks for clinical treatment of HIV

2013-11-26
(Press-News.org) Contact information: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-343-7593
University of Montreal
Risk of HIV treatment failure present even in those with low viral load Study proposes new benchmarks for clinical treatment of HIV People with human immunodeficiency virus (HIV) run a higher risk of virologic failure than previously thought, even when their number of RNA copies of the retrovirus per millilitre of blood is slightly above the detection threshold, according to a study by Claudie Laprise at the University of Montreal's Department of Social and Preventative Medicine. Her findings were published in Clinical Infectious Diseases. The study was conducted in close collaboration with doctors from the Clinique médicale du Quartier Latin de Montréal, based on data from the files of 1,860 people living with HIV and covering a period of 12 years. Nearly 94% of the patients were men.

Minimizing the presence of the retrovirus

The prognosis for people with HIV has considerable improved since the advent of antiretroviral therapy (ART) in 1996. ART acts by reducing the presence of the retrovirus in the blood of infected people. This maintains the immune functions required to prevent the disease from progressing to acquired immunodeficiency syndrome (AIDS). From a clinical point of view, the viral load test measures the activity of HIV in the patient and the effectiveness of ART. The goal of treatment is to keep the viral load below the detection limit, which is about 50 copies of viral RNA/ml.

Reducing the risk of virologic failure

Despite treatment, patients sometimes show persistent low viral load during medical follow-up, from 50 to 1,000 copies/ml, for a number of months. The higher the persistent viral loads, the higher the patients are at risk of developing virologic failure. "Virologic failure, defined in this study as a viral load above 1,000 copies/ml of viral RNA in the blood, is to be avoided, not least because it shows the progression of the disease," Laprise explained.

Her results confirm that the risk of virologic failure is a function of persistent viral load. Thus, a patient with a persistent viral load between 500 and 999 copies/ml after a six-month follow-up runs a five times higher risk of virologic failure compared to patients whose viral load is undetectable.

However, a persistent low viral load (50 to 199 copies/ml) doubles this risk as much as an "average" persistent viral load (200 to 499 copies/ml). "This result surprised us because we did not believe that a load as low as 50 to 199 copies/ml after 6 months could result in a significant risk of virologic failure," said Laprise.

According to her, this represents important clinical data: for now, there is still no consensus on the therapeutic way forward in the presence of persistent low viral load.

Indeed, in such circumstances, doctors may decide to alter the patient's therapy or continue to observe the patient without changing the therapeutic approach. "To the extent that our results are confirmed by other studies, our findings could provide a new element in assessing the situation of people with HIV, because of the potential risk factors our data have uncovered," Laprise said.

What is HIV/AIDS?

The human immunodeficiency virus (HIV) is a retrovirus infecting humans and causing acquired immunodeficiency syndrome (AIDS), which is a weakened immune system increasing vulnerability to multiple opportunistic infections.

Transmitted by several bodily fluids, HIV is now considered a pandemic that has killed about 25 million people between 1981 (when the first case of AIDS was identified) and January 2006.

Although antiretroviral therapy (ART) can control HIV, there is still no vaccine or cure. Prevention, which notably includes safe sex and knowing one's HIV status to prevent infection in others, is the most effective means of control.

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

MR spectroscopy shows differences in brains of preterm infants

2013-11-26
MR spectroscopy shows differences in brains of preterm infants CHICAGO – Premature birth appears to trigger developmental processes in the white matter of the brain that could put children at higher risk of problems later in life, according to a study ...

New tool developed for profiling critical regulatory structures of RNA molecules

2013-11-25
New tool developed for profiling critical regulatory structures of RNA molecules A molecular technique that will help the scientific community to analyze -- on a scale previously impossible -- molecules that play a critical role in regulating gene expression has been ...

Your first hug: How the early embryo changes shape

2013-11-25
Your first hug: How the early embryo changes shape In research published today in Nature Cell Biology, scientists from the EMBL Australia research team based at Monash University's Australian Regenerative Medicine Institute (ARMI) have revealed new ...

Pill-popping galaxy hooked on gas

2013-11-25
Pill-popping galaxy hooked on gas Our Galaxy may have been swallowing "pills" — clouds of gas with a magnetic wrapper — to keep making stars for the past eight billion years. That's the conclusion of CSIRO astronomer Dr Alex Hill, lead author of a study of the Smith Cloud, ...

Black hole jets pack a powerful punch

2013-11-25
Black hole jets pack a powerful punch High-speed 'jets' spat out by black holes pack a lot of power because they contain heavy atoms, astronomers have found. Black-hole jets recycle matter and energy into space and can affect when and where a galaxy forms stars. "Jets ...

The mushrooms, my friend, are blowing in the wind...

2013-11-25
The mushrooms, my friend, are blowing in the wind... Research at the APS Division of Fluid Dynamics Meeting in Pittsburgh shows how the mushroom spews its spores WASHINGTON D.C. Nov. 25, 2013 -- Plants use a variety of methods to spread their seeds, including ...

JCI early table of contents for Nov. 25, 2013

2013-11-25
JCI early table of contents for Nov. 25, 2013 Predicting nasopharyngeal carcinoma patient response to radiation therapy Nasopharyngeal carcinoma (NPC) affects cells lining the nasopharynx. The majority of NPC cases can be cured by radiation therapy, ...

Predicting nasopharyngeal carcinoma patient response to radiation therapy

2013-11-25
Predicting nasopharyngeal carcinoma patient response to radiation therapy Nasopharyngeal carcinoma (NPC) affects cells lining the nasopharynx. The majority of NPC cases can be cured by radiation therapy, however ~20% are resistant to radiation treatment. ...

Circadian clock proteins maintain neuronal cell function

2013-11-25
Circadian clock proteins maintain neuronal cell function The circadian clock synchronizes the molecular activity of cells to their environment. The "core clock" of the circadian system is made up of a group of proteins that autonomously activate and ...

Identifying targets of autoantibodies

2013-11-25
Identifying targets of autoantibodies Patients with the autoimmune disease systemic lupus erythematosus (SLE) produce autoantibodies that target can cause damage to multiple organ systems. The host factors that are targeted by autoantibodies produced ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Risk of HIV treatment failure present even in those with low viral load
Study proposes new benchmarks for clinical treatment of HIV